Viewing Study NCT00535418


Ignite Creation Date: 2025-12-25 @ 4:34 AM
Ignite Modification Date: 2026-02-24 @ 4:15 PM
Study NCT ID: NCT00535418
Status: COMPLETED
Last Update Posted: 2017-09-05
First Post: 2007-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer View
None neoadjuvant treatment View
None treatment duration View
None Primary hormone receptor positive View
None breast cancer in postmenopausal women View